3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow CXA-10: new trials by email Literature Review of CXA-10 trials Research Report on CXA-10
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral CXA-10 in Pulmonary Arterial Hypertension CXA-10 - Pulmonary Arterial Hypertension | Phase 2 | Terminated | Gladwin, Mark, MD | 1 | 2019-10-31 | 2022-01-12 |
| CXA-10 Study in Subjects With Pulmonary Arterial Hypertension CXA-10 - PAH | Phase 2 | Terminated | Complexa, Inc. | 33 | 2019-08-09 | 2020-08-26 |
| PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) 75mg CXA-10, 150mg CXA-10, Placebo - PAH | Phase 2 | Terminated | Complexa, Inc. | 69 | 2018-08-01 | 2020-08-10 |
Pulmonary Arterial Hypertension (3) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Familial Primary Pulmonary Hypertension (2) · Hypertension (2) · Hypertension, Pulmonary (2) · Lung Diseases (2) · Vascular Diseases (2)
Complexa, Inc. (2) · Gladwin, Mark, MD (1)
United States (3) · United Kingdom (2)
Theo Danoff, MD (2) · Marc Simon, MD (1)
P01HL103455 (1)